To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: Core-binding factor β subunit (CBFB; CBF-β); myosin heavy chain 11 smooth muscle (MYH11; SMMHC); runt-related transcription factor 1 (RUNX1)

Cancer

INDICATION: Acute myelogenous leukemia (AML)

In vitro, mouse and patient sample studies suggest a small molecule protein-protein inhibitor could

Read the full 185 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE